FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News

One Shot or Two? What to Know About HPV Vaccination Recommendations

— Guidance is evolving

What's Behind Boy's Bullous Skin Lesions After Flu Symptoms?

Mycoplasma pneumonia identified as the culprit in this case of RIME

Meta's $17.1 Billion Settlement: A Chance for a Social Media Natural Experiment

Whether it advances the science depends on who can study the results

CDC, Epidemiologists Work on Definition for Measles Deaths

Standard workgroup process began over the summer

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

Todays Updates

Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD Samantha Pettigrew, MD

At CHEST 2026, Pettigrew reviewed STRATIFY and STORM-PE data, citing bleeding risk with low-dose alteplase and 90-day walk gains with thrombectomy.

AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD Jean Bourbeau, MD

At CHEST 2026, Jean Bourbeau, MD, said AI may support COPD diagnosis, remote monitoring, and posthospital care, though most tools still need validation.

Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD Henrik Watz, MD, PhD

Henrik Watz, MD, discusses 104-week OBERON, TITANIA, and PROSPERO data on tozorakimab in COPD presented at CHEST 2026.

Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD Gabor Kovacs, MD, PhD

Gabor Kovacs, MD, PhD, discusses phase 2a INSIGNIA PH-COPD results for inhaled frespaciguat presented at CHEST 2026.

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

Todays Updates

Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD Samantha Pettigrew, MD

At CHEST 2026, Pettigrew reviewed STRATIFY and STORM-PE data, citing bleeding risk with low-dose alteplase and 90-day walk gains with thrombectomy.

AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD Jean Bourbeau, MD

At CHEST 2026, Jean Bourbeau, MD, said AI may support COPD diagnosis, remote monitoring, and posthospital care, though most tools still need validation.

Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD Henrik Watz, MD, PhD

Henrik Watz, MD, discusses 104-week OBERON, TITANIA, and PROSPERO data on tozorakimab in COPD presented at CHEST 2026.

Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD Gabor Kovacs, MD, PhD

Gabor Kovacs, MD, PhD, discusses phase 2a INSIGNIA PH-COPD results for inhaled frespaciguat presented at CHEST 2026.

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

Latest News

— Guidance is evolving

Mycoplasma pneumonia identified as the culprit in this case of RIME

Whether it advances the science depends on who can study the results

Standard workgroup process began over the summer

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

News All Time

Vax Beliefs of HHS Deputy Secretary Nominee Probed at Hearing

Chris Klomp praised the MMR vaccine, but Sen. Wyden said Klomp's answers "created confusion"

Inquiry Slams Hospital for Failure to Protect Babies After Nurse's Murder Conviction

Concerns were kept quiet as babies fell ill at hospital where Lucy Letby worked

Twins Conjoined at Head Separated; Brain-Eating Amoeba Source; Mercury-Laden Lotion

Health news and commentary gathered by MedPage Today staff

Where Does Medicine's Responsibility for Human Trafficking End?

Public health is political, but it doesn't have to be partisan, says Nicholas Peoples, MD

RFK Jr. Picks New USPSTF Members

Under Kennedy's scrutiny, the preventive services panel hasn't met in more than a year

Mysterious Stomach Rash Had Unusual Source

It stemmed from prolonged contact with a certain device

RFK Jr. Bolsters Vaccine Skepticism at Children's Health Defense Conference

"We have started to ask the questions that you ... have been asking for years," he said

Doc Running for Congress Calls RFK Jr. 'Dangerous and Incompetent'

Community health and vaccination rates are big issues for California pediatrician

Stuttering: New Consensus Statement Highlights Neurobiology

New consensus guideline frames stuttering as a neurobiological condition, emphasizing that physicians play a crucial role in diagnosis and ongoing management.

NHS Alliance Warns ADHD, Autism Costs Spiralling

NHS leaders say soaring ADHD and autism assessment costs are forcing service cuts and disrupting long-term planning.

Meta Settlement Falls Short on Teen Mental Health Protections, Whistleblower Says

(This August 27 story has been republished to add an image, with no changes to text.)

A Camp for Children With Brain Injuries Zips Ahead

A Pennsylvania camp gives children and young adults with brain injuries a place to connect, but federal funding for traumatic brain injury programs remains uncertain.

Gabapentin Not Linked to Better Outcomes for Kids’ Migraine

For children hospitalized with migraine, gabapentin use wasn’t associated with less pain or fewer readmissions than no use in an observational study.

This 'Natural' Remedy Was Likely Culprit in Baby's Lead Poisoning

Clinicians should ask parents about all meds, traditional and complementary, expert advises

Are Suicide Attempts Contagious in Young People?

— "We know that suicidal behavior does not occur in a social vacuum," researcher says

Dravet Syndrome: Optimizing Early Diagnosis and Treatment Strategies

Dravet Syndrome: Optimizing Early Diagnosis and Treatment Strategies

Recommended News For You

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries

In myelofibrosis, combinations of rufolitinib reduce spleen volume.

Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

healthy despite having advanced cancer.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

Recommended Articles For You

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases 

Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide  

Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care 

Chronic Disease Clustering in Communities: Epidemiology, Mechanisms, and Clinical Implications 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

2.

FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.

3.

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

4.

Specific suicidal patterns mark the highest risk.

5.

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

1.

Florinef: Understanding Its Uses and Side Effects 

2.

Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients

3.

Tumor Microenvironment Secretome Mapping in Cancer Biology

4.

Beyond Symptoms: The Predictive Promise of Targeted Radionuclide Therapy in Palliative Oncology

5.

Tumor-Adjacent Tissue Regeneration Models: Scientific Foundations and Clinical Implications

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

2.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

3.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

4.

Emerging Concepts in Hematology

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot